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Abstract 
• 
We examined prevalence and correlates of fecal 
occult blood testing (FOBT) uptake in a sample 
of men and women aged 50 to 70 years with­
out a personal history of cancer (n= 15810). 
The data was collected in 2004 through the 
Health Care Access Panel (HCAP), a nationally 
generalizable survey of German households. A 
pronounced gender difference in FOBT use 
emerged. Women reported regular use more of­
ten, while men reported irregular use with a 
higher frequency. Nearly every third men 
(29.6%), compared to 17.5% of the women had 
never made use of FOBT. The influence of socio­
economic factors on FOBT uptake was negligi­
ble. Family history of cancer was significantly 
associated with FOBT but the effect was very 
small. Use of medical checkups and physician 
recommendation were the most important pre­
dictors of FOBT use in men and women. Gender 
differences in use of medical checkups and phy­
sician recommendation to undergo an examina­
tion for the early detection of cancer partly 
mediated the gender differences in FOBT use. 
Introduction 
T 
Over the last years, gender differences in colorec­
tal cancer test use have attracted the attention of 
several researchers, stemming from the fact that 
men in general are more reluctant to seek medi­
cal care and usually make less use of the health 
care system for preventive reasons [1­3] . Sever­
al European studies reported a higher utilization 
of fecal occult blood tests (FOBT) in women than 
men [4­9] , a phenomenon which was also dis­
cussed on the 2007 European conference on co­
lon cancer prevention in Brussels (see for exam­
ple the contributions by Malila, Segnan or Steele 
in this supplement). 
In Germany, fecal occult blood testing with He­
moccult was introduced as the standard proce­
dure for the early detection of colorectal cancer in 
1977. It was offered annually to individuals from 
age 50 and paid by mandatory public health insur­
ance. All measures for the early detection of can­
cer take place by opportunistic screening rather 
than the eligible population receiving an invita­
tion letter. Since its introduction women have dis­
played higher levels of FOBT use than men, espe­
cially in the younger age groups [4, 10]. In 2002, 
eligibility to undergo a screening colonoscopy ev­
ery ten years was added to the standard catalog of 
measures of secondary prevention. Since then in­
dividuals from age 55 can choose whether they 
want to have a colonoscopy every ten years or a 
FOBT every two years. Between ages 50 ­ 54 the 
FOBT is still offered annually. Analyses show a 
marked gender difference in use of screening colo­
noscopies especially in lower age groups as well 
(see G. Brenner, this supplement [11,12]). 
Since only little is known about gender differences 
regarding correlates of colorectal cancer (CRC) test 
use [2,13] a main goal of our study was to assess 
gender differences in prevalence of FOBT use as 
well as in the correlates of that use. So far, most 
studies assessed FOBT use dichotomously for a 
specific time frame (usually the last year or the 
last two years). Similarly, the prevalence estimates 
of CRC test use from official statistics in Germany 
only give an indication of use within the last year 
[14]. Assessing it thus yields no information as to 
how regular FOBT use occurs. As regularity of 
FOBT use is a prerequisite for the effectiveness 
(the sensitivity is low if the test is performed only 
once) we assessed use of FOBT by three possible 
options (never, irregularly, regularly every 1 ­ 2 
years). We also included sociodemographic meas­
ures (age, marital status, income or education) 
which had been identified as correlates of CRC 
test use in various studies [15­18]. Several vari­
ables can serve as "cues to action" to (colorectal) 
Sieverding M et al. Gender Differences in... Z Gastroenterol 2008; 46: S47-S51 
S48 Originals 
cancer screening as previous research has demonstrated, for in­
stance family history of cancer [2, 17], number of physician visits 
[13,16], physician recommendation [17] and use of general medi­
cal checkups [19]. These variables were also assessed. 
Correlates of regularity of FOBT use were analysed by linear mul­
tiple hierarchical regressions, entering sociodemographic vari­
ables (including sex) in the first step, and the cues to action vari­
ables in the second step. 
Method 
• 
Participants and Procedure 
The data for the study were collected through the Health Care 
Access Panel (HCAP) [20]. It uses a sampling method specifical­
ly designed to arrive at samples representing the characteris­
tics of the population at large. The HCAP of the year 2004 con­
tained 71446 persons, aged 2 0 ­ 7 0 years. The sample for the 
present study was constituted by selecting all persons aged 
50 ­ 70 from the HCAP and originally consisted of 17146 adults. 
1336 persons with a personal history of cancer were excluded 
from the study. The final sample for the present study com­
prised 15810 adults (7735 men and 8075 women) aged 5 0 ­
70, the mean age was 58 years (men: M = 58.1, SD = 5.5, wo­
men: M = 58.3, SD = 5.7). All of the participants were health in­
sured. Data collection took place between August and October 
2004 by mailed questionnaires. 
Measures 
T 
Sociodemographic variables 
Sociodemographic variables included age in years, marital sta­
tus, family size, education (9th grade or under, 10th grade, High 
school certificate, College graduate), monthly family income 
and health insurance status (public versus private). 
Fecal occult blood test (FOBT) use 
Participants were asked whether and how regularly they had 
undergone a test of fecal occult blood in the past with the possi­
ble answers "never", "irregularly", "regularly every 1 ­ 2 years". 
Cues to action variables: Family history of cancer, physi­
cian recommendation and use of medical checkups 
Family history of cancer was assessed by asking the partici­
pants whether they had knowledge of (any) cancer amongst 
their grand parents, parents or siblings ("no", "yes, one per­
son", "yes, two or more persons"). Physician recommendation 
was assessed by asking participants whether a physician had 
recommended they undergo a test for the early detection of 
cancer ( l=yes , 0 = no/I don't know). Use of general medical 
checkups was measured by asking participants to indicate on 
a four­point scale ("never", "irregularly", "every two years" or 
"annually") whether and how regularly they had attended a 
free medical checkup as provided by the German health care 
system starting at age 35. 
The development of the questionnaire involved piloting and pre­
testing the items in independent samples to ensure its clarity 
and comprehension. 
Statistical analyses and data transformation 
Final data were weighed to be nationally representative for all 
analyses with the exception of the sample description. Statisti­
cal analyses were carried out using SPSS for Windows (Version 
14). Gender differences in prevalence rates of FOBT use were ex­
amined by x2­tests. 
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Results 
T 
Gender differences in sociodemographic variables 
Women lived alone more often, held fewer college degrees, re­
ported lower income and held a private health insurance less 
often than men. These results mirror the socioeconomic differ­
ences between men and women in the general German popu­
lation [21]. 
Gender differences in cues to action variables 
More women (48%) than men (39%) reported to have had one 
or more family member(s) with cancer. A higher percentage of 
women (66%) than men (54%) reported ever having received a 
recommendation to undergo an investigation for the early de­
tection of cancer from a physician. Women also attended med­
ical checkups more regularly than men. Every fourth man (26%) 
but only 14% of the women indicated never having attended a 
medical checkup. The characteristics of the study sample are 
displayed in O Table 1. 
Prevalence of FOBT use 
A pronounced gender difference emerged in the pattern of FOBT 
use. As can be seen from O Fig. 1 women had used FOBT on a 
regular basis more often than men { x 2 = 466.3, df=2, p < 0.001, 
Cramer's V = 0.18). While 63% of the women reported FOBT use 
every 1 ­ 2 years, the respective number for men was much 
smaller (46%); 30% of the men reported never having used a 
FOBT. 
Multivariate linear hierarchical regression models pre­
dicting regularity of FOBT use 
Sociodemographic variables were entered in the first step, to be 
followed by family history of cancer, physician recommendation 
and use of medical checkups in the second step (O Table 2). All 
sociodemographic variables including age and sex explained 
only a small amount of variance in FOBT use (5% = R2 = .05), 
most of which was attributable to sex. Sociodemographic vari­
ables appear to play only a negligible role in predicting FOBT 
use in our sample. Considering only first step variables, educa­
tion for example was no significant predictor and the other so­
ciodemographic variables although being significant added lit­
60 
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Table 1 Study population summary (n = 15 810 [persons wi thout a personal 
history of cancer]) 
men women 
(n = 7735) (n = 8075) 
% % p 
value 
age (years) <0.01 
5 0 - 5 4 31.5 34.2 
5 5 - 5 9 26.7 25.1 
6 0 - 6 4 25.1 24.1 
6 5 - 7 0 16.7 16.6 
marital status <0.001 
married 83.0 69.2 
single/separated/ 
divorced/widowed 
17.0 30.8 
family size <0.001 
1 11.2 20.8 
2 51.7 53.8 
3 20.2 16.6 
4 12.3 6.6 
>5 4.6 2.2 
education <0.001 
9 t h grade or under 4 8 . 7 49.6 
10 th grade HSHfli 3 3 . 3 high school graduat ion HHHBHi 6 . 4 
college graduat ion 1 9 . 1 1 0 . 7 
family income per month <0.001 
<1 7 5 0 € 3 3 . 1 4 5 . 1 
1 7 5 0 ­ 2 7 4 9 € 3 5 . 4 31.4 
> 2 7 5 0 € 3 1 . 5 2 3 . 5 
health insurance <0.001 
public 86.0 9 2 . 5 
private 1 4 . 0 7.5 
family cancer history <0.001 
no 60.9 5 2 . 1 
yes: 1 person 29.9 32.6 
yes: > 2 persons 15.3 
physician recommendation 
(cancer screening) 
<0.001 
no 46.4 3 3 . 9 
yes 53.6 6 6 . 1 
use of medical checkup <0.001 
never 25.6 1 4 . 2 
i rregularly 28.2 24.0 
every t w o years 21.0 22.3 
t ie to t h e p r e d i c t i o n of FOBT u s e as i n d i c a t e d by t h e i r sma l l b e ­
tas . W h e n s e c o n d s t e p var iab les w e r e a d d e d i nd iv idua l b e t a s of 
m o s t s o c i o d e m o g r a p h i c var i ab le s d e c r e a s e d e v e n f u r t h e r a n d 
e a c h s o c i o d e m o g r a p h i c va r i ab l e c o n t r i b u t e d on ly a m i n i m a l 
a m o u n t of u n i q u e va r i ance (all less t h a n 0.2%) to t h e p r e d i c t i o n 
of FOBT (O Table 2). 
A d d i n g t h e cues t o ac t i on var iab les phys ic i an r e c o m m e n d a ­
t ion, u s e of m e d i c a l c h e c k u p s a n d f a m i l y h i s t o r y of c a n c e r in 
t h e s e c o n d s t e p s ign i f i can t ly i m p r o v e d t h e p r e d i c t i v e p o w e r 
of t h e m o d e l (A R 2 = 0.35) . Use of m e d i c a l c h e c k u p s a n d p h y ­
sician r e c o m m e n d a t i o n e m e r g e d as t h e s t r o n g e s t pred ic to r s . A 
smal l e f f ec t w a s o b s e r v e d for f a m i l y h i s t o r y of cancer . Use of 
medica l c h e c k u p s c o n t r i b u t e d t h e l a rges t a m o u n t of u n i q u e 
va r i ance to t h e p r e d i c t i o n of FOBT (23%). 
As can b e s e e n in O Table 2 t h e i m p a c t of t h e va r i ab l e "sex" 
w a s n o t a b l y r e d u c e d in t h e s e c o n d s t e p w h e n cues to ac t i on 
Table 2 Results f rom linear hierarchical regression predict ing FOBT utiliza­
t ion1 
step 1 step 2 
predictor unique unique 
beta variance beta variance 
sociodemographic 
variables 
sex2 0.1 81 3.0% 0.063 0.3% 
age4 0.073 0.4% 0.033 <0.1 % 
marital status5 0.083 0.4% 0.033 <0.1 % 
family size6 ­0 .09 3 0.5% ­0 .04 3 <0.1 % 
education7 0.0114 <0.1 % 0.028 <0.1 % 
income9 0.083 0.4% 0.033 <0.1 % 
health insurance10 ­0 .01 1 4 <0.1 % 0.028 <0.1 % 
cues to action 
variables 
use of medical 
checkup11 
0.523 3.0% 
physician recom­
mendat ion1 2 
0.193 23.0% 
family history of 
cancer13 
0.043 0.1% 
A R 2 0.053 0.353 
H H H H H H H H H E H 
K cum(adjusted) 
0.05 0.40 
1 From 1 (never) to 3 (regularly every 1 ­ 2 years). 
2 ­ 1 = male, 1 = female. 
3 p < 0 . 0 0 1 . 
4 Age in years. 
5 0 = no partner, 1 = wi th partner. 
6 Scores f rom 1 ­ 5 ( 5 and more members). 
7 scores f rom 1 ­ 4. 
8 p < 0 . 0 5 . 
9 1 ­ 9 . 
10 ­ 1 = public, 1 = private. 
11 0 = never, 1 = irregularly, 2 = every 2 years, 3 = annually. 
12 0 = no, 1 = yes. 
13 0 = no, 1 = yes, oneperson ,2 = y e s m o r e t h a n o n e p e r s o n . 
14 Not signif icant 
var i ab le s w e r e a d d e d . Its u n i q u e v a r i a n c e d e c r e a s e d f r o m 3% 
(S tep 1) to 0.3% (S tep 2) i n d i c a t i n g cues to ac t ion var i ab le s ­
p a r t i c u l a r l y use of m e d i c a l c h e c k u p s ­ to p a r t l y m e d i a t e t h e 
g e n d e r d i f f e r e n c e in FOBT use . 
Discussion 
? 
W e f o u n d a s t r ik ing g e n d e r d i f f e r e n c e in FOBT use . A l a rge r per ­
c e n t a g e of m e n r e p o r t e d n e v e r h a v i n g u s e d t h e t e s t . The p e r c e n ­
t a g e of i r r e g u l a r u s e r s w a s also m u c h h i g h e r a m o n g m e n . T h e s e 
r e su l t s s u p p o r t f i n d i n g s f r o m p r e v i o u s s t u d i e s in w h i c h FOBT 
u s e t e n d e d to be gene ra l l y l o w e r in m e n as c o m p a r e d to w o m e n 
( see i n t r o d u c t i o n ) [13 ,16] . The s ize of t h i s e f f ec t w a s e v e n l a rger 
in o u r s t u d y w h i c h m a y be a t t r i b u t e d to t h e w a y w e a s s e s s e d 
FOBT use . Unlike m o s t p r e v i o u s s t u d i e s w h i c h a s s e s s e d FOBT 
u s e w i t h i n t h e l as t o n e or t w o years , w e a s k e d p a r t i c i p a n t s to re ­
p o r t r egu l a r i t y of FOBT use . In G e r m a n y t h e FOBT is o f t e n c o m ­
b i n e d w i t h a m e d i c a l c h e c k u p ; t h e f ac t t h a t m e n c o m p a r e d to 
w o m e n m a k e u s e of t h e s e c h e c k u p s less o f t e n a n d less r egu la r ly 
m a y exp la in t h e i r l o w e r u s e of FOBT. This backs t h e i n t e r n a t i o n ­
ally o b s e r v e d t r e n d of m e n to g e n e r a l l y m a k e less u s e of t h e 
h e a l t h ca re s y s t e m [1, 22], pa r t i cu l a r l y for p r e v e n t i v e r ea sons . 
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It appears that men have more difficulty engaging in a preven­
tive behavior which has to take place regularly (i.e. annually) 
than women. 
Men also reported family members with cancer significantly 
less often than women, a finding which was also reported by 
Wardle et al. [2] (UK) and McQueen et al. [13] (US). Compared 
to women, men are perhaps not as well informed about illness 
among their relatives (e.g. grandparents). Alternatively, they 
may tend to forget cancer in their family more readily. Glanz 
and colleagues [23] asked relatives of patients with colon can­
cer and found males more likely to be unaware of colorectal 
cancer in siblings or parents than females. 
Although a significant association between family history of 
cancer and FOBT use was noted, the effect was not strong. We 
did not assess family history of colorectal but any cancer; if we 
had, a stronger association might have been found. We found 
attendance of regular medical checkups a very high­ranking 
correlate of FOBT use. Individuals having undergone medical 
checkups regularly reported more regular use of FOBT. We also 
found an association between a physician recommendation and 
FOBT use. The important role of medical checkups and physician 
recommendation in colorectal cancer test use has been demon­
strated in a number of studies [16,19, 24, 25]. It appears that in­
dividuals being in regular contact with the medical system, for 
example by regularly seeing their doctor can be reached more 
easily to be reminded to undergo CRC early detection measures 
especially when screening is opportunistic and there is no invi­
tation system. 
Study limitations and strengths 
The present study used a cross­sectional design and no causal 
interpretations of the observed associations can be made. An­
other limitation refers to the assessment of the data by self­re­
port. When comparing self­report with medical record audit for 
several cancer tests Hall et al. [26] demonstrated over­reporting 
of previous cancer test participation by self­report. Although we 
cannot rule out over­reporting in our study, the observed gen­
der differences in the patterns of self­reported CRC test use par­
allel the findings from official statistics for the use of FOBT [4, 
14]. 
Positive aspects of the study pertain to the large sample, which 
was drawn using a method to arrive at samples representing 
the general population. Hence, the results are highly generaliz­
able. Furthermore, potential confounding effects of health in­
surance and other monetary inequalities play no role in Ger­
many since health insurance is mandatory and no additional 
payment is necessary for CRC tests. Another strength pertains 
to the fact that we assessed the regularity of FOBT use rather 
than (one­off) FOBT use within a particular time interval to re­
flect adherence to the recommended interval. 
Conclusions 
T 
Nearly half of the men in our sample had not received (or could 
not remember) a physician recommendation to undergo an 
early examination of cancer and every fourth man (26%) had 
never undergone a medical checkup, which highlights the need 
to intensify systematic counseling about preventive behavior 
and (colorectal) cancer testing especially for men. The evident 
gender difference in (recalled) family history of cancer as found 
in this and other studies should receive more attention in future 
research and also be acknowledged more in general and physi­
cian's practice. 
Note 
T 
This study was funded by a grant from "Deutsche Krebshilfe" 
(German Cancer Aid). 
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